Accendra Health, Inc. (ACH) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-5375.4%

-$12.89

vs $0.24 price

Levered DCF

-$35.35

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

0.27

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.2×	-2.76×	-35.69×	65.1×	14.26×	57.55×	-13.97×	-0.87×
P/B	-0.47×	1.77×	1.58×	1.54×	3.37×	2.41×	0.68×	0.73×
P/S	0.08×	0.09×	0.14×	0.15×	0.32×	0.2×	0.03×	0.04×
EV / EBITDA	9.86×	60.39×	9.28×	11.34×	10.26×	8.2×	9.05×	-7.2×
Gross margin	46.7%	20.7%	20.6%	18.3%	15.5%	15.1%	12.3%	11.4%
Operating margin	8.0%	-1.9%	1.0%	1.4%	3.8%	2.4%	0.8%	-3.7%
Net margin	-39.8%	-3.4%	-0.4%	0.2%	2.3%	0.4%	-0.7%	-4.6%
Current ratio	0.58×	1.08×	1.11×	1.47×	1.73×	1.59×	1.7×	1.72×
Debt / equity	-4.85×	3.79×	2.6×	2.95×	1.23×	1.6×	3.7×	3.18×
Interest coverage	2.07×	-1.44×	0.66×	1.11×	7.66×	2.45×	0.75×	-4.96×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.7%	12.7%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.3%	2.2%	-8.4%	-11.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	238.8%	-64.2%	-4.5%	2.4%	23.6%	4.2%	-13.5%	-84.3%
Return on invested capital	12.3%	-7.4%	2.3%	3.7%	13.2%	8.1%	2.5%	-15.3%
Return on assets	-44.9%	-7.8%	-0.8%	0.4%	6.3%	0.9%	-1.7%	-11.6%
Free cash flow yield	-140.8%	-6.6%	36.5%	10.9%	2.4%	16.3%	36.4%	13.1%
Earnings yield	-511.2%	-36.2%	-2.8%	1.5%	7.0%	1.7%	-19.9%	-115.0%
Enterprise value	$2.2B	$3.1B	$3.6B	$4.2B	$4.3B	$2.7B	$2B	$2B
Net debt / EBITDA	8.88×	40.81×	5.54×	7.39×	2.64×	3.06×	7.6×	-5.81×
Cash conversion cycle (days)	-59	18	18	36	47	42	42	39